A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells., Proceedings of the National Academy of Sciences, vol.91, issue.11, pp.4935-4939, 1994. ,
Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor, Science, vol.264, issue.5161, pp.965-968, 1994. ,
Interleukin-15 in the treatment of cancer, Expert Review of Clinical Immunology, vol.10, issue.12, pp.1689-1701, 2014. ,
Interleukin 15: biology and relevance to human disease, Blood, vol.97, issue.1, pp.14-32, 2001. ,
Free IL-15 Is More Abundant Than IL-15 Complexed With Soluble IL-15 Receptor-? in Murine Serum: Implications for the Mechanism of IL-15 Secretion, Endocrinology, vol.157, issue.3, pp.1315-1320, 2016. ,
Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor., Journal of Experimental Medicine, vol.180, issue.4, pp.1395-1403, 1994. ,
Functional characterization of the human interleukin-15 receptor alpha chain and close linkage of IL15RA and IL2RA genes, J Biol Chem, vol.270, pp.29862-29871, 1995. ,
IL-15/IL-15R? intracellular trafficking in human melanoma cells and signal transduction through the IL-15R?, Oncogene, vol.19, issue.45, pp.5153-5162, 2000. ,
The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design, Nature Reviews Immunology, vol.6, issue.8, pp.595-601, 2006. ,
Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens, Journal of Clinical Oncology, vol.26, issue.32, pp.5233-5239, 2008. ,
Up-regulation of NK Cell Activating Receptors Following Allogeneic Hematopoietic Stem Cell Transplantation under a Lymphodepleting Reduced Intensity Regimen is Associated with Elevated IL-15 Levels, Biology of Blood and Marrow Transplantation, vol.14, issue.3, pp.290-300, 2008. ,
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells, Journal of Experimental Medicine, vol.202, issue.7, pp.907-912, 2005. ,
Inflammatory Signals Regulate IL-15 in Response to Lymphodepletion, The Journal of Immunology, vol.196, issue.11, pp.4544-4552, 2016. ,
Membrane-bound and soluble IL-15/IL-15R? complexes display differential signaling and functions on human hematopoietic progenitors, Blood, vol.106, issue.7, pp.2302-2310, 2005. ,
Soluble Interleukin-15 Receptor ? (IL-15R?)-sushi as a Selective and Potent Agonist of IL-15 Action through IL-15R?/?, Journal of Biological Chemistry, vol.281, issue.3, pp.1612-1619, 2005. ,
IL-15.IL-15R complex shedding following trans-presentation is essential for the survival of IL-15 responding NK and T cells, Proceedings of the National Academy of Sciences, vol.111, issue.23, pp.8565-8570, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-02437298
Converting IL-15 to a superagonist by binding to soluble IL-15R, Proceedings of the National Academy of Sciences, vol.103, issue.24, pp.9166-9171, 2006. ,
Combined IL-15/IL-15R? Immunotherapy Maximizes IL-15 Activity In Vivo, The Journal of Immunology, vol.177, issue.9, pp.6072-6080, 2006. ,
IL-15R? Recycles and Presents IL-15 In trans to Neighboring Cells, Immunity, vol.17, issue.5, pp.537-547, 2002. ,
The interleukin-15/interleukin-15 receptor system as a model for juxtacrine and reverse signaling, BioEssays, vol.28, issue.4, pp.362-377, 2006. ,
Monocyte Surface-Bound IL-15 Can Function as an Activating Receptor and Participate in Reverse Signaling, The Journal of Immunology, vol.172, issue.7, pp.4225-4234, 2004. ,
Elevated Expression of Transmembrane IL-15 in Immune Cells Correlates with the Development of Murine Lupus: a Potential Target for Immunotherapy Against SLE, Scandinavian Journal of Immunology, vol.69, issue.2, pp.119-129, 2009. ,
Crystal Structure of the Interleukin-15·Interleukin-15 Receptor ? Complex, Journal of Biological Chemistry, vol.282, issue.51, pp.37191-37204, 2007. ,
Coordinate Expression and Trans Presentation of Interleukin (IL)-15R? and IL-15 Supports Natural Killer Cell and Memory CD8+ T Cell Homeostasis, Journal of Experimental Medicine, vol.200, issue.7, pp.825-834, 2004. ,
Macrophage-and dendriticcell-derived interleukin-15 receptor alpha supports homeostasis of distinct CD8+ T cell subsets, Cancer Res, vol.31, pp.1561-1570, 2009. ,
PS1-57 Different dynamics of IL-15R activation following IL-15 cis- or trans-presentation, Cytokine, vol.52, issue.1-2, p.29, 2010. ,
Interleukin-15 and Its Soluble Receptor Mediate the Response to Infliximab in Patients With Crohn's Disease, Gastroenterology, vol.138, issue.7, pp.2378-2387, 2010. ,
Circulating IL-15 exists as heterodimeric complex with soluble IL-15R? in human and mouse serum, Blood, vol.120, issue.1, pp.e1-e8, 2012. ,
Serum and muscle interleukin-15 levels decrease in aging mice: Correlation with declines in soluble interleukin-15 receptor alpha expression, Experimental Gerontology, vol.45, issue.2, pp.106-112, 2010. ,
Characterization of serum interleukin-15 in healthy volunteers and patients with early arthritis to assess its potential use as a biomarker, Eur Cytokine Netw, vol.21, pp.186-94, 2010. ,
Serum levels of interleukin 15 in patients with rheumatic diseases, J Rheumatol, vol.28, pp.2389-91, 2001. ,
Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-?) receptors in type C chronic liver disease, Clinical & Experimental Immunology, vol.109, issue.3, pp.458-463, 1997. ,
Age-Related Modifications in Circulating IL-15 Levels in Humans, Mediators of Inflammation, vol.2005, issue.4, pp.245-247, 2005. ,
Soluble Interleukin-15 Complexes Are Generated In Vivo by Type I Interferon Dependent and Independent Pathways, PLOS ONE, vol.10, issue.3, p.e0120274, 2015. ,
Increased serum soluble IL-15R? levels in T-cell large granular lymphocyte leukemia, Blood, vol.119, issue.1, pp.137-143, 2012. ,
Natural Splicing of Exon 2 of Human Interleukin-15 Receptor ?-Chain mRNA Results in a Shortened Form with a Distinct Pattern of Expression, Journal of Biological Chemistry, vol.274, issue.38, pp.26978-26984, 1999. ,
Natural, Proteolytic Release of a Soluble Form of Human IL-15 Receptor ?-Chain That Behaves as a Specific, High Affinity IL-15 Antagonist, The Journal of Immunology, vol.173, issue.3, pp.1681-1688, 2004. ,
URL : https://hal.archives-ouvertes.fr/inserm-02437358
The Soluble Chain of Interleukin-15 Receptor: A Proinflammatory Molecule Associated with Tumor Progression in Head and Neck Cancer, Cancer Research, vol.68, issue.10, pp.3907-3914, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-01679874
Paracrine and Transpresentation Functions of IL-15 Are Mediated by Diverse Splice Versions of IL-15R? in Human Monocytes and Dendritic Cells, Journal of Biological Chemistry, vol.287, issue.48, pp.40328-40338, 2012. ,
Interleukin-15 Triggers the Proliferation and Cytotoxicity of Granular Lymphocytes in Patients With Lymphoproliferative Disease of Granular Lymphocytes, Blood, vol.89, issue.1, pp.201-211, 1997. ,
Interleukin-15 Is an Autocrine/Paracrine Viability Factor for Cutaneous T-Cell Lymphoma Cells, Blood, vol.92, issue.1, pp.252-258, 1998. ,
Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF- B site, Proceedings of the National Academy of Sciences, vol.95, issue.5, pp.2452-2457, 1998. ,
Human T Cell Lymphotropic Virus Type I Tax Activates IL-15R? Gene Expression Through an NF-?B Site, The Journal of Immunology, vol.166, issue.4, pp.2602-2609, 2001. ,
Expression of functional interleukin-15 receptor and autocrine production of interleukin-15 as mechanisms of tumor propagation in multiple myeloma, Blood, vol.95, issue.2, pp.610-618, 2000. ,
Identification of a predictive gene expression signature of cervical lymph node metastasis in oral squamous cell carcinoma, Cancer Science, vol.98, issue.5, pp.740-746, 2007. ,
Use of a Cytokine Gene Expression Signature in Lung Adenocarcinoma and the Surrounding Tissue as a Prognostic Classifier, JNCI: Journal of the National Cancer Institute, vol.99, issue.16, pp.1257-1269, 2007. ,
IL-15 is produced by a subset of human melanomas, and is involved in the regulation of markers of melanoma progression through juxtacrine loops, Oncogene, vol.16, issue.19, pp.2503-2512, 1998. ,
Role of interleukin (IL)-2 and IL-15 in the tumour progression of a melanoma cell line MELP, derived from an IL-2 progressor patient, Melanoma Research, vol.7, issue.SUPPLEMENT 2, p.S19, 1997. ,
IL-15 is a component of the inflammatory milieu in the tumor microenvironment promoting antitumor responses, Proceedings of the National Academy of Sciences, vol.116, issue.2, pp.599-608, 2018. ,
IL15RA Drives Antagonistic Mechanisms of Cancer Development and Immune Control in Lymphocyte-Enriched Triple-Negative Breast Cancers, Cancer Research, vol.74, issue.17, pp.4908-4921, 2014. ,
Interleukin-15 is a major regulator of the cell-microenvironment interactions in human renal homeostasis, Cytokine & Growth Factor Reviews, vol.24, issue.1, pp.13-22, 2013. ,
Human Renal Normal, Tumoral, and Cancer Stem Cells Express Membrane-Bound Interleukin-15 Isoforms Displaying Different Functions, Neoplasia, vol.17, issue.6, pp.509-517, 2015. ,
Transmembrane-Bound IL-15?Promoted Epithelial-Mesenchymal Transition in Renal Cancer Cells Requires the Src-Dependent Akt/GSK-3?/?-Catenin Pathway, Neoplasia, vol.17, issue.5, pp.410-420, 2015. ,
Interleukin-15 Plays a Central Role in Human Kidney Physiology and Cancer through the ?c Signaling Pathway, PLoS ONE, vol.7, issue.2, p.e31624, 2012. ,
Differentiation Therapy: Targeting Human Renal Cancer Stem Cells with Interleukin 15, JNCI: Journal of the National Cancer Institute, vol.103, issue.24, pp.1884-1898, 2011. ,
Chemokine Markers Predict Biochemical Recurrence of Prostate Cancer following Prostatectomy, Clinical Cancer Research, vol.14, issue.23, pp.7790-7797, 2008. ,
IL-15 regulates migration, invasion, angiogenesis and genes associated with lipid metabolism and inflammation in prostate cancer, PLOS ONE, vol.12, issue.4, p.e0172786, 2017. ,
Conjugated linoleic acid inhibits peritoneal metastasis in human gastrointestinal cancer cells, International Journal of Cancer, vol.118, issue.3, pp.571-576, 2005. ,
Interleukin-15 Expression Is Associated with Malignant Potential in Colon Cancer Cells, Pathobiology, vol.69, issue.2, pp.86-95, 2001. ,
Functional Network Pipeline Reveals Genetic Determinants Associated with in Situ Lymphocyte Proliferation and Survival of Cancer Patients, Science Translational Medicine, vol.6, issue.228, pp.228ra37-228ra37, 2014. ,
IL-15 and HIV Infection: Lessons for Immunotherapy and Vaccination, Current HIV Research, vol.3, issue.3, pp.261-270, 2005. ,
IL-15: targeting CD8+ T cells for immunotherapy, Cytotherapy, vol.7, issue.1, pp.23-35, 2005. ,
Determinants of Successful CD8 + T-Cell Adoptive Immunotherapy for Large Established Tumors in Mice, Clinical Cancer Research, vol.17, issue.16, pp.5343-5352, 2011. ,
Simultaneous Blockade of Multiple Immune System Inhibitory Checkpoints Enhances Antitumor Activity Mediated by Interleukin-15 in a Murine Metastatic Colon Carcinoma Model, Clinical Cancer Research, vol.16, issue.24, pp.6019-6028, 2010. ,
Interleukin-15 combined with an anti-CD40 antibody provides enhanced therapeutic efficacy for murine models of colon cancer, Proceedings of the National Academy of Sciences, vol.106, issue.18, pp.7513-7518, 2009. ,
Intratumoral Injection of Dendritic Cells Transduced by an SV40-Based Vector Expressing Interleukin-15 Induces Curative Immunity Mediated by CD8+ T Lymphocytes and NK Cells, Molecular Therapy, vol.12, issue.5, pp.950-959, 2005. ,
Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-?, CXCL9 and CXCL10, Journal for ImmunoTherapy of Cancer, vol.8, issue.1, p.e000599, 2020. ,
High antitumor activity of RLI, an interleukin-15 (IL-15)-IL-15 receptor fusion protein, in metastatic melanoma and colorectal cancer, Molecular Cancer Therapeutics, vol.8, issue.9, pp.2736-2745, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-02440759
IL-15 Superagonist?Mediated Immunotoxicity: Role of NK Cells and IFN-?, The Journal of Immunology, vol.195, issue.5, pp.2353-2364, 2015. ,
IL-15 superagonist RLI has potent immunostimulatory properties on NK cells: implications for antimetastatic treatment, Journal for ImmunoTherapy of Cancer, vol.8, issue.1, p.e000632, 2020. ,
IL-15 Trans-Signaling with the Superagonist RLI Promotes Effector/Memory CD8+ T Cell Responses and Enhances Antitumor Activity of PD-1 Antagonists, The Journal of Immunology, vol.197, issue.1, pp.168-178, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01823361
Characterization and Favorablein VivoProperties of Heterodimeric Soluble IL-15·IL-15R? Cytokine Compared to IL-15 Monomer, Journal of Biological Chemistry, vol.288, issue.25, pp.18093-18103, 2013. ,
Heterodimeric IL15 Treatment Enhances Tumor Infiltration, Persistence, and Effector Functions of Adoptively Transferred Tumor-specific T Cells in the Absence of Lymphodepletion, Clinical Cancer Research, vol.23, issue.11, pp.2817-2830, 2016. ,
IL-15 Superagonist Expands mCD8+ T, NK and NKT Cells after Burn Injury but Fails to Improve Outcome during Burn Wound Infection, PLOS ONE, vol.11, issue.2, p.e0148452, 2016. ,
IL-15 enhances the anti-tumor activity of trastuzumab against breast cancer cells but causes fatal side effects in humanized tumor mice (HTM), Oncotarget, vol.8, issue.2, pp.2731-2744, 2016. ,
Mature natural killer cells with phenotypic and functional alterations accumulate upon sustained stimulation with IL-15/IL-15R complexes, Proceedings of the National Academy of Sciences, vol.107, issue.50, pp.21647-21652, 2010. ,
INTERLEUKIN-15 INTERACTIONS WITH INTERLEUKIN-15 RECEPTOR COMPLEXES: CHARACTERIZATION AND SPECIES SPECIFICITY, Cytokine, vol.20, issue.3, pp.121-129, 2002. ,
High dose CD11c-driven IL15 is sufficient to drive NK cell maturation and anti-tumor activity in a trans-presentation independent manner, Scientific Reports, vol.6, issue.1, 2016. ,
NK cells control breast cancer and related cancer stem cell hematological spread, OncoImmunology, vol.6, issue.3, p.e1284718, 2017. ,
Control of Metastasis by NK Cells, Cancer Cell, vol.32, issue.2, pp.135-154, 2017. ,
Fatal Leukemia in Interleukin-15 Transgenic Mice, Blood Cells, Molecules, and Diseases, vol.27, issue.1, pp.223-230, 2001. ,
Emergence of NK Cell Hyporesponsiveness after Two IL-15 Stimulation Cycles, The Journal of Immunology, vol.201, issue.2, pp.493-506, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-01805185
MODULATION OF NK ACTIVITY BY RECOMBINANT LEUKOCYTE INTERFERON IN ADVANCED CANCER PATIENTS, NK Cells and Other Natural Effector Cells, vol.131, pp.1279-1283, 1982. ,
IL-15 Is Expressed by Dendritic Cells in Response to Type I IFN, Double-Stranded RNA, or Lipopolysaccharide and Promotes Dendritic Cell Activation, The Journal of Immunology, vol.167, issue.3, pp.1179-1187, 2001. ,
Ionomycin Treatment Renders NK Cells Hyporesponsive, PLOS ONE, vol.11, issue.3, p.e0150998, 2016. ,
Cutting Edge: The Role of IFN-? Receptor and MyD88 Signaling in Induction of IL-15 Expression In Vivo, The Journal of Immunology, vol.188, issue.6, pp.2483-2487, 2012. ,
Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice, Journal of Clinical Investigation, vol.120, issue.2, pp.607-616, 2010. ,
First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia, Blood Advances, vol.3, issue.13, pp.1970-1980, 2019. ,
IL-15 in the Combination Immunotherapy of Cancer, Frontiers in Immunology, vol.11, p.868, 2020. ,
IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion, Clinical Cancer Research, vol.25, issue.16, pp.4945-4954, 2019. ,
Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer, Journal of Clinical Oncology, vol.33, issue.1, pp.74-82, 2015. ,
The potential and promise of IL-15 in immuno-oncogenic therapies, Immunology Letters, vol.190, pp.159-168, 2017. ,
Phase I Trial of ALT-803, A Novel Recombinant IL15 Complex, in Patients with Advanced Solid Tumors, Clinical Cancer Research, vol.24, issue.22, pp.5552-5561, 2018. ,
First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation, Blood, vol.131, issue.23, pp.2515-2527, 2018. ,
Interleukin 15 Pharmacokinetics and Consumption by a Dynamic Cytokine Sink, Frontiers in Immunology, vol.11, p.1813, 2020. ,
A First-in-Human Phase I Study of Subcutaneous Outpatient Recombinant Human IL15 (rhIL15) in Adults with Advanced Solid Tumors, Clinical Cancer Research, vol.24, issue.7, pp.1525-1535, 2017. ,
ALT-803 Transiently Reduces Simian Immunodeficiency Virus Replication in the Absence of Antiretroviral Treatment, Journal of Virology, vol.92, issue.3, p.1, 2017. ,
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial, The Lancet Oncology, vol.19, issue.5, pp.694-704, 2018. ,
Continuous treatment with IL-15 exhausts human NK cells via a metabolic defect, JCI Insight, vol.3, issue.3, 2018. ,
Elucidation of the Interleukin-15 Binding Site on Its Alpha Receptor by NMR, Biochemistry, vol.46, issue.33, pp.9453-9461, 2007. ,
Abstract 3245: IL-15 superagonist/IL-15R?Sushi-Fc fusion complex (IL-15SA/IL-15R?Su-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity of murine breast and colon carcinomas, Immunology, 2016. ,
IL-15 superagonist/IL-15R?Sushi-Fc fusion complex (IL-15SA/IL-15R?Su-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity against murine breast and colon carcinomas, Oncotarget, vol.7, issue.13, pp.16130-16145, 2016. ,
IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in Melanoma, Clinical Cancer Research, vol.26, issue.20, pp.5520-5533, 2020. ,
CIS is a potent checkpoint in NK cell?mediated tumor immunity, Nature Immunology, vol.17, issue.7, pp.816-824, 2016. ,
Augmented IL-15R? Expression by CD40 Activation Is Critical in Synergistic CD8 T Cell-Mediated Antitumor Activity of Anti-CD40 Antibody with IL-15 in TRAMP-C2 Tumors in Mice, The Journal of Immunology, vol.188, issue.12, pp.6156-6164, 2012. ,
Novel combination immunotherapy for pancreatic cancer: potent anti?tumor effects with CD40 agonist and interleukin?15 treatment, Clinical & Translational Immunology, vol.9, issue.8, p.1165, 2020. ,
Enhancing the Activation and Releasing the Brakes: A Double Hit Strategy to Improve NK Cell Cytotoxicity Against Multiple Myeloma, Frontiers in Immunology, vol.9, p.2743, 2018. ,
Interleukin-15 and cancer: some solved and many unsolved questions, Journal for ImmunoTherapy of Cancer, vol.8, issue.2, p.e001428, 2020. ,
URL : https://hal.archives-ouvertes.fr/inserm-03013809
Highly potent anti-CD20-RLI immunocytokine targeting established human B lymphoma in SCID mouse, mAbs, vol.6, issue.4, pp.1026-1037, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01680794
Tumor targeting of the IL-15 superagonist RLI by an anti-GD2 antibody strongly enhances its antitumor potency, International Journal of Cancer, vol.133, issue.3, pp.757-765, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-02440732
Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal Models, Cancer Immunology Research, vol.4, issue.1, pp.49-60, 2015. ,
The IL-15-Based ALT-803 Complex Enhances Fc RIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas, Clinical Cancer Research, vol.22, issue.3, pp.596-608, 2015. ,
The multi-functionality of N-809, a novel fusion protein encompassing anti-PD-L1 and the IL-15 superagonist fusion complex, OncoImmunology, vol.8, issue.2, p.e1532764, 2018. ,
Effectiveness of two different dose administration regimens of an IL-15 superagonist complex (ALT-803) in an orthotopic bladder cancer mouse model, Journal of Translational Medicine, vol.17, issue.1, p.29, 2019. ,
Evaluation of the biological activities of the IL-15 superagonist complex, ALT-803, following intravenous versus subcutaneous administration in murine models, Cytokine, vol.107, pp.105-112, 2018. ,
Abstract 3245: IL-15 superagonist/IL-15R?Sushi-Fc fusion complex (IL-15SA/IL-15R?Su-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity of murine breast and colon carcinomas, Immunology, 2016. ,
IL-15 superagonist/IL-15R?Sushi-Fc fusion complex (IL-15SA/IL-15R?Su-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity against murine breast and colon carcinomas, Oncotarget, vol.7, issue.13, pp.16130-16145, 2016. ,
Therapeutic administration of IL-15 superagonist complex ALT-803 leads to long-term survival and durable antitumor immune response in a murine glioblastoma model, International Journal of Cancer, vol.138, issue.1, pp.187-194, 2015. ,
Efficacy and Mechanism-of-Action of a Novel Superagonist Interleukin-15: Interleukin-15 Receptor Su/Fc Fusion Complex in Syngeneic Murine Models of Multiple Myeloma, Cancer Research, vol.73, issue.10, pp.3075-3086, 2013. ,
The IL-15-Based ALT-803 Complex Enhances Fc RIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas, Clinical Cancer Research, vol.22, issue.3, pp.596-608, 2015. ,
Interleukin-15 enhances rituximab-dependent cytotoxicity against chronic lymphocytic leukemia cells and overcomes transforming growth factor beta-mediated immunosuppression, Experimental Hematology, vol.39, issue.11, pp.1064-1071, 2011. ,
A Novel Fusion of ALT-803 (Interleukin (IL)-15 Superagonist) with an Antibody Demonstrates Antigen-specific Antitumor Responses, Journal of Biological Chemistry, vol.291, issue.46, pp.23869-23881, 2016. ,
IL-15 enhanced antibody-dependent cellular cytotoxicity mediated by NK cells and macrophages, Proceedings of the National Academy of Sciences, vol.115, issue.46, pp.E10915-E10924, 2018. ,
Preassociation of IL-15 with IL-15R?-IgG1-Fc Enhances Its Activity on Proliferation of NK and CD8+/CD44high T Cells and Its Antitumor Action, The Journal of Immunology, vol.180, issue.4, pp.2099-2106, 2008. ,
Augmented IL-15R? Expression by CD40 Activation Is Critical in Synergistic CD8 T Cell-Mediated Antitumor Activity of Anti-CD40 Antibody with IL-15 in TRAMP-C2 Tumors in Mice, The Journal of Immunology, vol.188, issue.12, pp.6156-6164, 2012. ,
Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model, Proceedings of the National Academy of Sciences, vol.109, issue.16, pp.6187-6192, 2012. ,
Development of a recombinant human IL-15·sIL-15R?/Fc superagonist with improved half-life and its antitumor activity alone or in combination with PD-1 blockade in mouse model, Biomedicine & Pharmacotherapy, vol.112, p.108677, 2019. ,
Mechanisms involved in IL-15 superagonist enhancement of anti-PD-L1 therapy, Journal for ImmunoTherapy of Cancer, vol.7, issue.1, p.82, 2019. ,
Functional and mechanistic advantage of the use of a bifunctional anti-PD-L1/IL-15 superagonist, Journal for ImmunoTherapy of Cancer, vol.8, issue.1, p.e000493, 2020. ,